Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland · Delayed Price · Currency is CHF 56.20
+0.50 (0.90%)
Aug 5, 2025, 9:40 AM CET
Basilea Pharmaceutica AG Employees
Basilea Pharmaceutica AG had 164 employees as of December 31, 2024. The number of employees increased by 17 or 11.56% compared to the previous year.
Employees
164
Change (1Y)
17
Growth (1Y)
11.56%
Revenue / Employee
1.27M CHF
Profits / Employee
473.13K CHF
Market Cap
683.34M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 164 | 17 | 11.56% |
| Dec 31, 2023 | 147 | 6 | 4.26% |
| Dec 31, 2022 | 141 | -13 | -8.44% |
| Dec 31, 2021 | 154 | -3 | -1.91% |
| Dec 31, 2020 | 157 | -68 | -30.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Novartis AG | 75,883 |
| Lonza Group AG | 18,944 |
| Alcon | 25,599 |
| Galderma Group AG | 6,545 |
| Sandoz Group AG | 22,049 |
| Straumann Holding AG | 11,815 |
| Sonova Holding AG | 18,366 |
Basilea Pharmaceutica AG News
- 3 months ago - Assessment of the 14-Alpha Demethylase Inhibitors Pipeline Landscape 2025, Featuring Insights Into Oteseconazole (Mycovia Pharmaceuticals) and Isavuconazonium (Basilea Pharmaceutica) - GlobeNewsWire
- 3 months ago - Strong sales for Cresemba® (isavuconazole) in Japan trigger second milestone payment from Asahi Kasei Pharma to Basilea - GlobeNewsWire
- 5 months ago - Basilea Pharmaceutica Ltd (XSWX:BSLN) Full Year 2024 Earnings Call Highlights: A Year of Robust ... - GuruFocus
- 5 months ago - Full Year 2024 Basilea Pharmaceutica AG Allschwil Earnings Call Transcript - GuruFocus
- 5 months ago - Basilea projects CHF220M in 2025 revenue with key pipeline advancements and U.S. launch of Zevtera - Seeking Alpha
- 5 months ago - Basilea Pharmaceutica AG (BPMUF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Basilea Pharmaceutica AG 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 6 months ago - Basilea Pharmaceutica GAAP EPS of CHF5.83, revenue of CHF208.5M; initiates FY25 outlook - Seeking Alpha